GYRE THERAPEUTICS, INC. (GYRE) Profit Margins
Over the twelve months to 2026-06-30, GYRE THERAPEUTICS, INC. (GYRE) had operating margin -14.0%, net margin -23.6%, free cash flow margin -5.1%, according to EquiReason's reading of its SEC filings.
Source: SEC EDGAR filings · figures as of 2026-06-30 · read by EquiReason
GYREGYRE THERAPEUTICS, INC.Follow GYRE — free
—
Price chart with a free account
- Market cap
- 652.3M
- P/E TTM
- —
- Dividend yield
- —
- 52-week
- —
- Next earnings
- 18 Nov, in 25 days
| Line | FY2011 Dec 11 | FY2012 Dec 12 | FY2013 Dec 13 | FY2014 Dec 14 | FY2018 Dec 18 | FY2020 Dec 20 | FY2021 Dec 21 | FY2022 Dec 22 | FY2023 Dec 23 | FY2024 Dec 24 | FY2025 Dec 25 | TTM Jun 26 | Trend |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross margin | — | — | — | — | — | — | — | — | 95.9% | 96.3% | 95.4% | — | |
| Operating margin | -10.0% | -14.1% | -278.9% | -2730.5% | -563700.0% | -273.9% | -1197.8% | 9.0% | -59.3% | 15.3% | 9.9% | -14.0% | |
| Net margin | -8.7% | -12.1% | -274.6% | -2404.7% | -500916.7% | -268.5% | -1198.3% | 4.2% | -75.3% | 16.9% | 8.5% | -23.6% | |
| FCF margin | -87.2% | -111.6% | -1120.2% | -2324.7% | -482150.0% | — | -1152.8% | 5.6% | 15.3% | -5.6% | -0.2% | -5.1% |
USD millions · SEC XBRL
GYRE THERAPEUTICS, INC. — questions
- What is GYRE THERAPEUTICS, INC.'s operating margin?
- -14.0% over the twelve months to 2026-06-30.
- What is GYRE THERAPEUTICS, INC.'s net profit margin?
- -23.6% over the twelve months to 2026-06-30.
Every figure on this page comes from GYRE THERAPEUTICS, INC.'s own SEC filings — see them on SEC EDGAR. Price data is licensed and shown only inside the product.
How these figures are read: methodology · EquiReason.